AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

8,314.00p
   
  • Change Today:
      38.00p
  • 52 Week High: 9,444.00
  • 52 Week Low: 6,794.00
  • Currency: UK Pounds
  • Shares Issued: 1,549.16m
  • Volume: 1,933,858
  • Market Cap: £128,797m
  • RiskGrade: 123
  • Beta: 0.36

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.
Registrars: Equiniti
Brands: Losec, Prilosec, Nexium, Crestor

Key Personnel

Senior Independent Non-Executive Director: Philip A J Broadley
CEO and Executive director: Pascal Soriot
CFO & Executive Director: Aradhana Sarin
Non-Executive Chairman: Leif Johansson
Non-Executive Dir: Sheri McCoy, Andreas Rummelt, Euan Ashley, Deborah DiSanzo, Marcus Wallenberg, Diana Layfield , Tony Mok, Nazneen Rahman, Michel Demare

Contact Details

Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge,United Kingdom, CB2 0AA
Phone: +44 (0)20 3749 5000
Fax: +44 (0)20 7604 8151
Website: http://www.astrazeneca.com

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARKFTSE 100FTSEurofirst 300FTSE 350FTSE All-Share
Overseas Listings: BATSLON:AZNL, NYSE:AZN
ISIN: GB0009895292

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 8,314.00p
Change Today 38.00p
% Change 0.46 %
52 Week High 9,444.00
52 Week Low 6,794.00
Volume 1,933,858
Shares Issued 1,549.16m
Market Cap £128,797m
Beta 0.36
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.65% below the market average84.65% below the market average84.65% below the market average84.65% below the market average84.65% below the market average
26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average
Price Trend
21.22% above the market average21.22% above the market average21.22% above the market average21.22% above the market average21.22% above the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average
Income
33.33% below the market average33.33% below the market average33.33% below the market average33.33% below the market average33.33% below the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Growth
87.43% above the market average87.43% above the market average87.43% above the market average87.43% above the market average87.43% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average

What The Brokers Say

Strong Buy 22
Buy 3
Neutral 2
Sell 0
Strong Sell 0
Total 27
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 12-Aug-21 25-Feb-21
Paid 13-Sep-21 29-Mar-21
Amount 90.00¢ 190.00¢

Trades for 01-Dec-2021

Time Volume / Share Price
16:38 220 @ 8,314.00p
16:35 796,803 @ 8,314.00p
16:30 62 @ 8,327.00p
16:29 63 @ 8,326.00p
16:29 44 @ 8,326.00p

Top of Page